Literature DB >> 19890311

NICE should value real experiences over hypothetical opinions.

Paul Dolan.   

Abstract

Mesh：

Year:  2009        PMID： 19890311     DOI： 10.1038/462035a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Whom should we ask? A systematic literature review of the arguments regarding the most accurate source of information for valuation of health states.

Authors:  Olivia Ernstsson; Mimmi Åström; Gert Helgesson; Kristina Burström
Journal:  Qual Life Res       Date:  2020-02-03       Impact factor: 4.147

2.  Integrating evidence on patient preferences in healthcare policy decisions: protocol of the patient-VIP study.

Authors:  Carmen D Dirksen; Cecile Ma Utens; Manuela A Joore; Teus A van Barneveld; Bert Boer; Dunja Hh Dreesens; Hans van Laarhoven; Cees Smit; Anne M Stiggelbout; Trudy van der Weijden
Journal:  Implement Sci       Date:  2013-06-10       Impact factor: 7.327

3.  Swedish experience-based value sets for EQ-5D health states.

Authors:  Kristina Burström; Sun Sun; Ulf-G Gerdtham; Martin Henriksson; Magnus Johannesson; Lars-Åke Levin; Niklas Zethraeus
Journal:  Qual Life Res       Date:  2013-08-22       Impact factor: 4.147

Review 4.  Using QALYs in telehealth evaluations: a systematic review of methodology and transparency.

Authors:  Trine S Bergmo
Journal:  BMC Health Serv Res       Date:  2014-08-03       Impact factor: 2.655

5.  Using EQ-5D Data to Measure Hospital Performance: Are General Population Values Distorting Patients' Choices?

Authors:  Nils Gutacker; Thomas Patton; Koonal Shah; David Parkin
Journal:  Med Decis Making       Date:  2020-06-03       Impact factor: 2.583

6.  Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol.

Authors:  Tonya Moen Hansen; Ylva Helland; Liv Ariane Augestad; Kim Rand; Knut Stavem; Andrew Garratt
Journal:  BMJ Open       Date:  2020-06-11       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.